www.syros.com. As previously reported, on January 6, 2025 the Company received deficiency letters from the Listing Qualifications Department of Nasdaq providing notice that the Company was out of ...
Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading ...
I could go on about these quirks ... option on the top variants at a cost of Rs 80,000 more. A fully-kitted out Syros would cost as much as the mid-variants of larger SUVs like Kia’s own ...
Explore Syros Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRS. US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff ...
Syros Pharmaceuticals stock opened at $0.17 on Friday. Syros Pharmaceuticals has a fifty-two week low of $0.16 and a fifty-two week high of $7.96. The stock has a market cap of $4.49 million, a P ...
Kia Syros review dashboard (Image: Express Drives) That said, customers have to shell out an additional Rs 80,000 to avail the ADAS suite. Other notable safety features include six airbags ...
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the “Company”) today announced that its Board of Directors (the “Board”) has approved and the Company intends to proceed with the voluntary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback